CLRB · Cellectar Biosciences, Inc.
$2.40
-0.07 (-2.83%)
At close · Jul 24
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$19.26M
Shares
7.99M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2014-03-31 | $31,667 | 10-Q, filed 2014-05-14 |
| 2013-12-31 | $31,667 | 10-K, filed 2014-03-19 |
| 2013-09-30 | $31,667 | 10-Q, filed 2013-11-13 |
| 2013-06-30 | $31,667 | 10-Q, filed 2013-08-12 |
| 2013-03-31 | $31,667 | 10-Q, filed 2013-05-15 |
| 2012-12-31 | $0 | 10-K, filed 2014-03-19 |
| 2012-09-30 | $31,667 | 10-Q, filed 2012-11-06 |
| 2012-06-30 | $31,667 | 10-Q, filed 2012-08-09 |
| 2012-03-31 | $31,667 | 10-Q, filed 2012-05-04 |
| 2011-12-31 | $0 | 10-K, filed 2013-03-28 |
| 2011-09-30 | $31,667 | 10-Q, filed 2011-11-07 |
| 2011-06-30 | $31,667 | 10-Q, filed 2011-08-12 |